While use of GLP-1s might cut bariatric surgery costs, covering anti-obesity medications in 2023 added 4.8 percentage points to the average plan's prescription spending increase.
A team of investigators found that health plans corrected or removed just 38% of the inaccurate entries within about a year, instead of 90 days required by federal law.